UNAUDITED
FINANCIAL RESULTS Of IND-SWIFT LABORATORIES LIMITED FOR THE QUARTER ENDED 30TH JUNE,
2002
(RS. IN LACS)
PARTICULARS
3 MONTHS 31.06.2002
UNAUDITED
3 MONTHS 31.06.2001 UNAUDITED
12 MONTHS 31.3.2002 AUDITED
Net Sales/Operational Income
2834.69
2331.44
11280.92
Others Income
9.86
6.51
40.08
TOTAL EXPENDITURE :
2491.26
2068.98
9911.25
(a) Increase/decrease in stock in trade
127.89
146.49
73.77
(b) Consumption of Raw Material
2256.46
1965.56
8638.82
(c) Staff Cost
55.67
32.22
216.07
(d) Other expenditure
307.03
217.69
1130.12
Interest
156.01
112.09
617.69
Depreciation
55.04
38.83
183.61
Profit(+)/Loss(-) before tax
142.24
118.04
608.46
Provision for taxation
10.00
9.00
42.00
Provision for deferred tax
35.00
32.00
127.40
Profit / Loss
97.24
77.04
439.06
Paid up Equity Share Capital
-
-
1095.58
Reserves excluding revaluation reserves
-
-
1710.44
EPS (Rs) : (Not Annulised)
-Basic
-Diluted
0.88
0.88
0.77
0.70
0.77
0.70
Notes:
a) During the Quarter under review, the turnover
of the company has increased by 21.59 % and the net profit by 26.22% over the corresponding
figures of the previous quarter.
b) The Company has forfeited all the 1,75,900
equity shares on which the allotment money was due since 1997.
c) The Company is exclusively in the pharmaceutical
business segment.
d) The above financial results were taken on
record by the Board in its meeting held on 30th July, 2002.
For Ind-Swift Laboratories Limited
Sd/-
Sd/-
Place:Chandigarh
(N.R.MUNJAL)
(V.K.MEHTA)
Date:30.07.2002
Managing Director
Jt.Managing Director
To know about our Formulation Division, please visit us at
Ind-Swift Limited, our other group company.
